XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1
DERIVATIVE LIABILITY
9 Months Ended
Apr. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE LIABILITY [Text Block]

9. DERIVATIVE LIABILITY

The exercise price of the Company's share purchase warrants is fixed in Canadian dollars and the functional currency of the Company is the USD. These warrants are considered to be a derivative as a variable amount of cash in the Company's functional currency will be received on exercise of the warrants. Accordingly, the share purchase warrants issued as part of past financings, are classified and accounted for as a derivative liability.

The following table shows a continuity of the Company's derivative liability:

    Warrant derivative     Number of warrants
accounted for as
derivative liability
 
Balance, July 31, 2020 $ 2,218,107     11,159,919  
Expiry   -     (5,679,836 )
Fair value adjustment   (1,776,341 )   -  
Balance, July 31, 2021 $ 441,766     5,480,083  
Expiry   -     (488,438 )
Fair value adjustment   (252,324 )   -  
Balance, April 30, 2022 $ 189,442     4,991,645  

For the nine-month period ended April 30, 2022, the Company recorded a total gain on fair value of derivative liability of $252,324 during the period (April 30, 2021 -$1,560,945).

The following weighted average assumptions were used for the Black-Scholes pricing model valuation of warrants as at April 30, 2022 and July 31, 2021:

     
April 30, 2022
     
July 31, 2021
 
             
Risk-free interest rate   1.52%     1.52%  
Expected life of warrants   0.18 to 0.30 years     0.08 to 1.14 years  
Expected annualized volatility   74.54% to 103.60%     83.6% to 118.2%  
Dividend   Nil     Nil  
Forfeiture rate   0%     0%